FLGT Fulgent Genetics Inc

Price (delayed)

$22.34

Market cap

$668.51M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.57

Enterprise value

$614.24M

Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high ...

Highlights
Fulgent Genetics's debt has plunged by 98% YoY and by 65% from the previous quarter
The gross profit has contracted by 25% YoY but it has grown by 3.2% from the previous quarter
FLGT's gross margin is down by 4.3% year-on-year but it is up by 3.9% since the previous quarter
FLGT's quick ratio is down by 30% year-on-year and by 28% since the previous quarter
Fulgent Genetics's revenue has decreased by 21% YoY

Key stats

What are the main financial stats of FLGT
Market
Shares outstanding
29.92M
Market cap
$668.51M
Enterprise value
$614.24M
Valuations
Price to book (P/B)
0.59
Price to sales (P/S)
2.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.14
Earnings
Revenue
$287.53M
EBIT
-$159.92M
EBITDA
-$127.63M
Free cash flow
$18.78M
Per share
EPS
-$5.57
Free cash flow per share
$0.63
Book value per share
$37.94
Revenue per share
$9.66
TBVPS
$35.84
Balance sheet
Total assets
$1.23B
Total liabilities
$103.24M
Debt
$413,000
Equity
$1.13B
Working capital
$310.56M
Liquidity
Debt to equity
0
Current ratio
5.09
Quick ratio
4.71
Net debt/EBITDA
0.43
Margins
EBITDA margin
-44.4%
Gross margin
37.5%
Net margin
-57.7%
Operating margin
-67%
Efficiency
Return on assets
-12.8%
Return on equity
-13.9%
Return on invested capital
-17.2%
Return on capital employed
-13.9%
Return on sales
-55.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FLGT stock price

How has the Fulgent Genetics stock price performed over time
Intraday
2.38%
1 week
5.08%
1 month
10.21%
1 year
-44.16%
YTD
-22.73%
QTD
13.86%

Financial performance

How have Fulgent Genetics's revenue and profit performed over time
Revenue
$287.53M
Gross profit
$107.75M
Operating income
-$192.5M
Net income
-$165.95M
Gross margin
37.5%
Net margin
-57.7%
The gross profit has contracted by 25% YoY but it has grown by 3.2% from the previous quarter
Fulgent Genetics's revenue has decreased by 21% YoY
FLGT's gross margin is down by 4.3% year-on-year but it is up by 3.9% since the previous quarter

Growth

What is Fulgent Genetics's growth rate over time

Valuation

What is Fulgent Genetics stock price valuation
P/E
N/A
P/B
0.59
P/S
2.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.14
The price to book (P/B) is 72% lower than the 5-year quarterly average of 2.1 and 16% lower than the last 4 quarters average of 0.7
The company's equity fell by 11% YoY
FLGT's P/S is 38% below its 5-year quarterly average of 3.7 and 20% below its last 4 quarters average of 2.9
Fulgent Genetics's revenue has decreased by 21% YoY

Efficiency

How efficient is Fulgent Genetics business performance
The company's return on invested capital rose by 3.4% QoQ
FLGT's ROS is up by 3.5% since the previous quarter
The return on equity has declined by 2.2% since the previous quarter

Dividends

What is FLGT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FLGT.

Financial health

How did Fulgent Genetics financials performed over time
FLGT's quick ratio is down by 30% year-on-year and by 28% since the previous quarter
FLGT's current ratio is down by 28% year-on-year and by 27% since the previous quarter
Fulgent Genetics's debt is 100% less than its equity
FLGT's debt to equity has dropped by 100% year-on-year
Fulgent Genetics's debt has plunged by 98% YoY and by 65% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.